Skip to main content
Edward Fox, MD, Neurology, Round Rock, TX

EdwardFoxMD

Neurology Round Rock, TX

Neuroimmunology/Multiple Sclerosis, Sleep Medicine

Central Texas Neurology Consultants

Dr. Fox is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fox's full profile

Already have an account?

  • Office

    16040 Park Valley Dr
    Ste 100
    Round Rock, TX 78681
    Phone+1 512-218-1222
    Fax+1 512-218-1393

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Neurology, 1989 - 1992
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 1988 - 1989
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1990 - 2026
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The University of Illinois School of Medicine Rockford Is Considering Adding a New $ 100 Million Building to Its Campus for Rural Health Sciences
    The University of Illinois School of Medicine Rockford Is Considering Adding a New $ 100 Million Building to Its Campus for Rural Health SciencesAugust 13th, 2021
  • #AAN2019 — Ublituximab Safe, Well-Tolerated in Extension Study of Phase 2 Trial in Relapsing MS
    #AAN2019 — Ublituximab Safe, Well-Tolerated in Extension Study of Phase 2 Trial in Relapsing MSMarch 15th, 2019
  • #ECTRIMS2018 – Ublituximab Markedly Reduces Lesions, Promotes B-cell Depletion, Halts Disability Progression in Phase 2 Trial
    #ECTRIMS2018 – Ublituximab Markedly Reduces Lesions, Promotes B-cell Depletion, Halts Disability Progression in Phase 2 TrialSeptember 28th, 2018
  • Join now to see all